DK1056448T3 - Pharmaceutical combinations with tramadol - Google Patents

Pharmaceutical combinations with tramadol

Info

Publication number
DK1056448T3
DK1056448T3 DK99916744T DK99916744T DK1056448T3 DK 1056448 T3 DK1056448 T3 DK 1056448T3 DK 99916744 T DK99916744 T DK 99916744T DK 99916744 T DK99916744 T DK 99916744T DK 1056448 T3 DK1056448 T3 DK 1056448T3
Authority
DK
Denmark
Prior art keywords
tramadol
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Application number
DK99916744T
Other languages
Danish (da)
Inventor
Helmut Momberger
Marc Raber
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Application granted granted Critical
Publication of DK1056448T3 publication Critical patent/DK1056448T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
DK99916744T 1998-02-21 1999-02-17 Pharmaceutical combinations with tramadol DK1056448T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19807535A DE19807535A1 (en) 1998-02-21 1998-02-21 Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
PCT/DE1999/000428 WO1999042095A1 (en) 1998-02-21 1999-02-17 Pharmaceutical combinations containing tramadol

Publications (1)

Publication Number Publication Date
DK1056448T3 true DK1056448T3 (en) 2004-05-17

Family

ID=7858642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916744T DK1056448T3 (en) 1998-02-21 1999-02-17 Pharmaceutical combinations with tramadol

Country Status (26)

Country Link
EP (1) EP1056448B1 (en)
JP (1) JP2002503689A (en)
KR (1) KR100567154B1 (en)
CN (1) CN1141937C (en)
AR (1) AR018102A1 (en)
AT (1) ATE257700T1 (en)
AU (1) AU748993B2 (en)
BG (1) BG64888B1 (en)
BR (1) BR9909211A (en)
CZ (1) CZ291941B6 (en)
DE (2) DE19807535A1 (en)
DK (1) DK1056448T3 (en)
EA (1) EA002166B1 (en)
ES (1) ES2212549T3 (en)
HK (1) HK1035143A1 (en)
HU (1) HU225656B1 (en)
IL (1) IL137505A (en)
NO (1) NO327860B1 (en)
NZ (1) NZ506020A (en)
PL (1) PL204075B1 (en)
PT (1) PT1056448E (en)
SK (1) SK284937B6 (en)
TR (1) TR200002411T2 (en)
TW (1) TWI228040B (en)
WO (1) WO1999042095A1 (en)
ZA (1) ZA991212B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL347542A1 (en) * 1998-12-02 2002-04-08 Darwin Discovery Ltd Therapeutic product and its use
DE19940944B4 (en) * 1999-08-31 2006-10-12 Grünenthal GmbH Retarded, oral, pharmaceutical dosage forms
JP5042425B2 (en) * 2000-03-01 2012-10-03 ユーロセルティック ソシエテ アノニム Tramadol for the treatment of functional gastrointestinal diseases
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
DE10108122A1 (en) 2001-02-21 2002-10-02 Gruenenthal Gmbh Medicines based on tramadol
DE102004020220A1 (en) * 2004-04-22 2005-11-10 Grünenthal GmbH Process for the preparation of a secured against misuse, solid dosage form
DE10361596A1 (en) * 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
EP2813144A1 (en) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Analgesic compositions comprising an antihistamine
CA2749273C (en) 2008-01-09 2018-09-04 Charleston Laboratories, Inc. Pharmaceutical oral dosage form comprising a triptan and an antiemetic
CN102014625A (en) 2008-04-28 2011-04-13 佐吉尼克斯股份有限公司 Novel formulations for treatment of migraine
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
US20150290211A1 (en) * 2014-04-10 2015-10-15 Locl Pharma, Inc. Pharmaceutical compositions
EP3423041A4 (en) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. Pharmaceutical compositions
WO2018112061A1 (en) * 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis
JP7195660B1 (en) 2021-09-09 2022-12-26 壽製薬株式会社 Orally disintegrating tablet

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
AU528310B2 (en) * 1978-11-16 1983-04-21 Beecham Group Plc Composition of paracetamol and metoclopramide
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2712809B1 (en) * 1993-11-26 1996-04-12 Union Pharma Scient Appl New pharmaceutical composition intended for the preparation of a stable powder containing, as active ingredient, a combination of acetylsalicylic acid and metoclopramide.
FR2720936B1 (en) * 1994-06-08 1997-04-30 Synthelabo Powders based on metoclopramide and paracetamol or acetylsalicylic acid derivatives.
GB9523566D0 (en) * 1995-11-17 1996-01-17 Euro Celtique Sa Pharmaceutical formulation
FR2741532B1 (en) * 1995-11-28 1998-08-21 Bouchara Sa NOVEL PHARMACEUTICAL COMPOSITIONS WITH ANTIMIGRAINE ACTION AND THEIR METHOD OF PREPARATION
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Also Published As

Publication number Publication date
AU748993B2 (en) 2002-06-13
HK1035143A1 (en) 2001-11-16
HU225656B1 (en) 2007-05-29
JP2002503689A (en) 2002-02-05
EP1056448B1 (en) 2004-01-14
NZ506020A (en) 2002-05-31
NO327860B1 (en) 2009-10-05
WO1999042095A1 (en) 1999-08-26
TR200002411T2 (en) 2000-12-21
BR9909211A (en) 2000-11-14
CZ291941B6 (en) 2003-06-18
CN1141937C (en) 2004-03-17
BG104758A (en) 2001-04-30
BG64888B1 (en) 2006-08-31
SK284937B6 (en) 2006-02-02
DE59908305D1 (en) 2004-02-19
NO20004143L (en) 2000-09-27
PL204075B1 (en) 2009-12-31
TWI228040B (en) 2005-02-21
EA200000862A1 (en) 2001-02-26
ZA991212B (en) 1999-08-03
KR20010041110A (en) 2001-05-15
SK12172000A3 (en) 2001-04-09
HUP0100964A3 (en) 2003-09-29
ATE257700T1 (en) 2004-01-15
PL342546A1 (en) 2001-06-18
IL137505A0 (en) 2001-07-24
EA002166B1 (en) 2001-12-24
CN1291092A (en) 2001-04-11
CZ20002939A3 (en) 2000-12-13
IL137505A (en) 2005-07-25
EP1056448A1 (en) 2000-12-06
AR018102A1 (en) 2001-10-31
ES2212549T3 (en) 2004-07-16
KR100567154B1 (en) 2006-04-04
NO20004143D0 (en) 2000-08-18
DE19807535A1 (en) 1999-08-26
PT1056448E (en) 2004-05-31
AU3514899A (en) 1999-09-06
HUP0100964A2 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
DK1025241T3 (en) Protease variants with multiple substitutions
ID27415A (en) PHARMACEUTICAL COMPOSITION
DE60009395D1 (en) VIEW
ID25977A (en) DIAPON ONCE USE
ID24555A (en) DIAPON ONCE USE
ID23076A (en) DIAPON ONCE USE
ATE341990T1 (en) SIGMIDOSCOPE
ID27841A (en) THERAPEUTIC BIARILS
ID29089A (en) MOKSIFLOXASIN PHARMACEUTICAL PROPERTIES
ID29262A (en) PHARMACEUTICAL COMPOSITION
DK1466615T3 (en) Pharmaceutical preparation
NO994626L (en) Substituted benzamides
ID23083A (en) DIAPON ONCE USE
DK1056448T3 (en) Pharmaceutical combinations with tramadol
ID27201A (en) PHARMACEUTICAL COMPOSITION
ATE262513T1 (en) BENZOYLPYRIDAZINE
DE1118098T1 (en) MEHRFACHFLUSSIGELEKTROSPRÜHSCHNITTSTELLE
DK1051156T3 (en) Pharmaceuticals
FI980856A0 (en) Andningsskydd utrustad med en identifierare
IS5877A (en) New preparation
IS5879A (en) New preparation
FI982648A0 (en) Slungpaket
ATA126298A (en) VERPUFFUNGSKLAPPE
SE9801216D0 (en) Pharmaceuticals
ID26084A (en) AMINO ANTRASICLINON HERITIES